Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Finasteride and minoxidil together safely and effectively increase hair growth and density for androgenetic alopecia.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

MorrF improves hair growth better than minoxidil alone.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Hair loss linked to kidney stones in people under 60.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Treat hair loss with medicine, continue indefinitely.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Men with severe hair loss may have poorer sperm quality.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Finasteride improves hair growth in men with androgenetic alopecia.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride and minoxidil together work best for male hair loss.